Advanced search
Publication Cover
Leukemia & Lymphoma Volume 57, 2016 - Issue 5
Submit an article Journal homepage
571
Views
17
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Bone marrow abnormalities and early bone lesions in multiple myeloma and its precursor disease: a prospective study using functional and morphologic imaging

Manisha BhutaniMultiple Myeloma Section, Lymphoid Malignancies Branch, CCR, NCI, NIH, Bethesda, MD, USA; ;Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA;
,
Baris TurkbeyMolecular Imaging Program, CCR, NCI, NIH, Bethesda, MD, USA;
,
Esther TanMultiple Myeloma Section, Lymphoid Malignancies Branch, CCR, NCI, NIH, Bethesda, MD, USA;
,
Neha KordeMultiple Myeloma Section, Lymphoid Malignancies Branch, CCR, NCI, NIH, Bethesda, MD, USA; ;Memorial Sloan-Kettering Cancer Center, New York, NY, USA;
,
Mary KwokMultiple Myeloma Section, Lymphoid Malignancies Branch, CCR, NCI, NIH, Bethesda, MD, USA;
,
Elisabet E. ManasanchMultiple Myeloma Section, Lymphoid Malignancies Branch, CCR, NCI, NIH, Bethesda, MD, USA; ;The University of Texas MD Anderson Cancer Center, Houston, TX, USA;
,
Nishant TagejaMultiple Myeloma Section, Lymphoid Malignancies Branch, CCR, NCI, NIH, Bethesda, MD, USA;
,
Sham MailankodyMultiple Myeloma Section, Lymphoid Malignancies Branch, CCR, NCI, NIH, Bethesda, MD, USA;
,
Mark RoschewskiMultiple Myeloma Section, Lymphoid Malignancies Branch, CCR, NCI, NIH, Bethesda, MD, USA;
,
Marcia MulquinMultiple Myeloma Section, Lymphoid Malignancies Branch, CCR, NCI, NIH, Bethesda, MD, USA;
,
Ashley CarpenterMultiple Myeloma Section, Lymphoid Malignancies Branch, CCR, NCI, NIH, Bethesda, MD, USA;
,
Elizabeth LampingMultiple Myeloma Section, Lymphoid Malignancies Branch, CCR, NCI, NIH, Bethesda, MD, USA;
,
Alex R. MinterMultiple Myeloma Section, Lymphoid Malignancies Branch, CCR, NCI, NIH, Bethesda, MD, USA;
,
Brendan M. WeissMultiple Myeloma Section, Lymphoid Malignancies Branch, CCR, NCI, NIH, Bethesda, MD, USA; ;Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA;
,
Esther MenaMolecular Imaging Program, CCR, NCI, NIH, Bethesda, MD, USA;
,
Liza LindenbergMolecular Imaging Program, CCR, NCI, NIH, Bethesda, MD, USA;
,
Katherine R. CalvoHematology Section, DLM, CC, NIH, Bethesda, MD, USA
,
Irina MaricHematology Section, DLM, CC, NIH, Bethesda, MD, USA
,
Saad Z. UsmaniLevine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA;
,
Peter L. ChoykeMolecular Imaging Program, CCR, NCI, NIH, Bethesda, MD, USA;
,
Karen KurdzielMolecular Imaging Program, CCR, NCI, NIH, Bethesda, MD, USA;
&
Ola LandgrenMultiple Myeloma Section, Lymphoid Malignancies Branch, CCR, NCI, NIH, Bethesda, MD, USA; ;Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Correspondence[email protected]
 show all
Pages 1114-1121 | Received 08 Mar 2015, Accepted 31 Aug 2015, Published online: 07 Apr 2016

References

  • Dimopoulos MA, Hillengass J, Usmani S, et al. Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement. J Clin Oncol. 2015;33:657–664.
  • Moulopoulos LA, Dimopoulos MA, Smith TL, et al. Prognostic significance of magnetic resonance imaging in patients with asymptomatic multiple myeloma. J Clin Oncol. 1995;13:251–256.
  • Hillengass J, Fechtner K, Weber MA, et al. Prognostic significance of focal lesions in whole-body magnetic resonance imaging in patients with asymptomatic multiple myeloma. J Clin Oncol. 2010;28:1606–1610.
  • Kyle RA, Durie BG, Rajkumar SV, et al. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management. Leukemia. 2010;24:1121–1127.
  • Perez-Persona E, Vidriales MB, Mateo G, et al. New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells. Blood. 2007;110:2586–2592.
  • Dispenzieri A, Kyle RA, Katzmann JA, et al. Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma. Blood. 2008;111:785–789.
  • Bhutani M, Turkbey B, Tan E, et al. Bone marrow angiogenesis in myeloma and its precursor disease: a prospective clinical trial. Leukemia. 2014;28:413–416.
  • Rawstron AC, Orfao A, Beksac M, et al. Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders. Haematologica. 2008;93:431–438.
  • Zamagni E, Patriarca F, Nanni C, et al. Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation. Blood. 2011;118:5989–5995.
  • Rajkumar SV, Dimopoulos MA, Palumbo A, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15:e538–e548.
  • Siontis B, Kumar S, Dispenzieri A, et al. Positron emission tomography-computed tomography in the diagnostic evaluation of smoldering multiple myeloma: identification of patients needing therapy. Blood Cancer J. 2015;5:e364. doi: 10.1038/bcj.2015.87.
  • Zamagni E, Nanni C, Gay F, et al. 18F-FDG PET/CT FOCAL, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease. Leukemia. 2015 Oct 22. [Epub ahead of print]. doi: 10.1038/leu.2015.291.
  • Bhutani M, Landgren O. [Imaging in smoldering (asymptomatic) multiple myeloma. Past, present and future]. Radiologe. 2014;54:572, 574–581.
  • Spira D, Weisel K, Brodoefel H, et al. Can whole-body low-dose multidetector CT exclude the presence of myeloma bone disease in patients with monoclonal gammopathy of undetermined significance (MGUS)? Acad Radiol. 2012;19:89–94.
  • Durie BG, Waxman AD, D'Agnolo A, et al. Whole-body (18)F-FDG PET identifies high-risk myeloma. J Nucl Med. 2002;43:1457–1463.
  • Hillengass J, Weber MA, Kilk K, et al. Prognostic significance of whole-body MRI in patients with monoclonal gammopathy of undetermined significance. Leukemia. 2014;28:174–178.
  • Hanrahan CJ, Christensen CR, Crim JR. Current concepts in the evaluation of multiple myeloma with MR imaging and FDG PET/CT. Radiographics. 2010;30:127–142.
  • Turesson I, Kovalchik SA, Pfeiffer RM, et al. Monoclonal gammopathy of undetermined significance and risk of lymphoid and myeloid malignancies: 728 cases followed up to 30 years in Sweden. Blood. 2014;123:338–345.
  • Kyle RA, Therneau TM, Rajkumar SV, et al. A long–term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med. 2002;346:564–569.
  • Kyle RA, Therneau TM, Rajkumar SV, et al. Long-term follow-up of 241 patients with monoclonal gammopathy of undetermined significance: the original Mayo Clinic series 25 years later. Mayo Clin Proc. 2004;79:859–866.
  • Sachpekidis C, Goldschmidt H, Hose D, et al. PET/CT studies of multiple myeloma using (18) F-FDG and (18) F-NaF: comparison of distribution patterns and tracers' pharmacokinetics. Eur J Nucl Med Mol Imaging. 2014;41:1343–1353.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.